AXTI's Record Revenue and $500M+ Backlog Signal Operational Milestone, but Export Permits and Inventory Conversion Remain Key

What happened

AXT Inc. reported record quarterly revenues of $73.4 million, a sharp acceleration from $26.9 million in Q1 2026, driven by surging AI data center demand for indium phosphide substrates. The company also disclosed a backlog exceeding $500 million, indicating strong order visibility, while management reiterated plans to expand InP capacity, including the Beijing 6-inch line. This development appears to confirm that export permits have become more routine, allowing the conversion of backlog into shipments, a key gating factor previously flagged as the most significant challenge. However, the master report's caution remains relevant: inventory levels, working capital efficiency, and the sustainability of demand, particularly with Coherent's internal capacity expansion, still need monitoring. The stock, which had already risen 2000% over the past year to $49.85 by July 2026, now trades on elevated expectations; the new data may justify further gains but also increases the burden of proof for execution.

Implication

The record revenue and large backlog suggest that AXT's thesis has shifted from speculative to more execution-driven, but the valuation remains stretched with negative earnings and high EV/EBITDA. The key near-term question is whether the revenue surge is sustainable and backed by actual wafer shipments rather than one-time permit approvals or inventory liquidation. Investors should scrutinize the next quarterly filing for gross margin trends, working capital changes, and any disclosure on remaining export permit risks, especially for North America. Additionally, Coherent's ongoing internal InP capacity expansion could eventually reduce external sourcing need, so AXT's long-term growth may face a ceiling. A disciplined approach would be to wait for consecutive quarters of sustained revenue and improving cash conversion before adding to positions, despite the positive headline.

Thesis delta

The thesis shifts from 'wait for permit clarity' to 'verify execution sustainability' as the record revenue and backlog suggest prior bottlenecks are easing. The bull case becomes more plausible, but the stock's valuation still leaves little room for error, so we remain cautious until we see evidence of margin expansion and inventory normalization. If future reports confirm this trend with healthy cash flows, a stronger bullish stance would be warranted.